Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

SZSE:301093 Stock Report

Market Cap: CN¥2.8b

Jiangsu Hualan New Pharmaceutical MaterialLtd Past Earnings Performance

Past criteria checks 0/6

Jiangsu Hualan New Pharmaceutical MaterialLtd's earnings have been declining at an average annual rate of -8.4%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 2% per year. Jiangsu Hualan New Pharmaceutical MaterialLtd's return on equity is 3.6%, and it has net margins of 13.7%.

Key information

-8.4%

Earnings growth rate

-15.9%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate2.0%
Return on equity3.6%
Net Margin13.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Sep 03
Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Sep 03
Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Is Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) Trading At A 36% Discount?

Jun 07
Is Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) Trading At A 36% Discount?

Revenue & Expenses Breakdown

How Jiangsu Hualan New Pharmaceutical MaterialLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:301093 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 245928112840
30 Jun 246049513538
31 Mar 245939514239
31 Dec 2362311814436
30 Sep 2363110616136
30 Jun 236199815637
31 Mar 236109614936
01 Jan 235849414137
30 Sep 2258610813239
30 Jun 2269116413541
31 Mar 2278420614244
01 Jan 2282121614442
30 Sep 2178421412237
30 Jun 2163315110831
31 Mar 215091038825
31 Dec 20446817724
31 Dec 19460958920
31 Dec 18434867921
31 Dec 17388776816

Quality Earnings: 301093 has a large one-off gain of CN¥19.4M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 301093's current net profit margins (13.7%) are lower than last year (16.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 301093's earnings have declined by 8.4% per year over the past 5 years.

Accelerating Growth: 301093's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 301093 had negative earnings growth (-24%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).


Return on Equity

High ROE: 301093's Return on Equity (3.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:41
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wen DaiHuatai Research
Jiaqi ZhuZhongtai Securities Co. Ltd.